Mounjaro®
Starting from £179.99/mo
Start journey Learn moreTaking semaglutide every 5 days sits outside the licensed schedule. Wegovy and its weekly injection format are designed around a seven-day dosing cycle, and the timing is not flexible in the way the question implies. Missing or compressing the gap can disrupt the steady hormone levels the treatment depends on. This page explains why the schedule is fixed, what to do if your injection day shifts, and what a prescriber would advise if your routine makes a strict seven-day window difficult to keep.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Semaglutide works by activating GLP-1 receptors in a way that is calibrated to a seven-day half-life. The medicine builds to a steady concentration in your system over several weeks of weekly injections, which is precisely why the titration schedule (moving up through doses no faster than roughly every four weeks) works as it does. That stable level is what dampens appetite and slows gastric emptying consistently between doses.
Compressing the cycle to five days does not accelerate that process. It exposes your system to a higher-than-designed cumulative dose before the previous injection has fully cleared, which is where the increased side-effect risk comes in. The NHS semaglutide medicines page is unambiguous: this is a once-weekly medicine. The prescriber who reviews your treatment at each stage is working from that schedule when they assess how well you are tolerating your current dose.
So the short answer to whether you can take semaglutide every 5 days is: no, not as prescribed, and not safely without clinical input. The seven-day gap is structural, not arbitrary.
Life does occasionally shift a Monday into a Tuesday, or push a Friday dose into the weekend. The licensed schedule does allow a degree of flexibility, but it is measured in days, not compressed into five. The NHS guidance on missed doses advises that if you miss your usual injection day, you can take it within five days of the original date. If more than five days have passed, skip that dose and continue with your next scheduled injection as planned. Do not take a double dose to compensate.
This is the one scenario where a five-day gap is technically part of the guidance, not as a shortened repeat schedule, but as the outer limit of a late single dose. The distinction matters. Taking semaglutide every 5 days as a routine means you would be injecting roughly 1.4 times a week rather than once, which is an entirely different proposition. Anyone thinking about what taking Wegovy every 5 days would actually involve will find the answer is: not aligned with the medicine's licence.
If your routine genuinely makes a fixed weekly day difficult (shift patterns, travel, caring responsibilities) the right move is to discuss a permanent change of injection day with your prescriber, moving to a new consistent day rather than a compressed cycle.
There are situations where the timing of your dose may feel uncertain: you started a new pen and the date did not line up, you were unwell and delayed an injection, or you have read online that a slightly shorter gap might suit your schedule better. These are the questions our prescribers hear regularly, and they have a straightforward answer ready, but it does need to come from a prescriber who knows your current dose and how you have been tolerating it.
Self-adjusting the interval is not the same as adjusting an injection day. If you find you are wondering about whether six days is close enough, or on the other end, whether a longer gap causes problems, those questions have specific answers that depend on where you are in titration and your side-effect history. The NHS medicines page for semaglutide is a reliable starting point, and your Patient Information Leaflet covers missed-dose instructions in plain language. For anything beyond that, your prescriber is the right person to ask, not a forum thread.
For a broader look at how semaglutide works and what the full treatment picture involves, the semaglutide treatment overview on this site covers the licensed evidence base in detail. If you are considering private treatment and want to understand what is included in a private prescription service, the Wegovy pricing page sets out what a transparent, all-in cost actually covers. And if you are curious about what happens when the medicine eventually clears your system, this page on how semaglutide leaves your body answers that directly.
Treatment with Wegovy is a prescription-only arrangement, and a real clinician reviews your suitability before anything is prescribed, at starting dose and at every repeat. If you have questions about your schedule or are thinking about whether this treatment is right for you, the right first step is a clinical consultation, not a change to your injection timing. You can start your free consultation with our prescribers at any point.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.